Beta‐agonist vs control
Early all‐cause mortality (≤ 3 months) Reported at: 28 days; 60 days; and during hospital stay · adults with acute respiratory distress syndrome
Beta‐agonist showed no clear difference in early all‐cause mortality (≤ 3 months) Reported at: 28 days; 60… compared with control (moderate certainty).
1 finding from 1 review
- Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes onlyRR 1.14 [0.91, 1.42]3 studies · 646 participantsModerate